跳至主要内容
临床试验/ACTRN12613000818730
ACTRN12613000818730撤回4 期

A Prospective, Comparative Study of Warfarin Management post Mechanical Heart Valve Replacement Surgery over a 12 week period to determine: time to achieve an initial stable therapeutic INR (defined as the first measured INR within the range of 2-2.5 for mechanical aortic valves and 3-3.5 for mechanical mitral valves; where the previous/subsequent two INRs vary by no more than 0.5); time INR is in therapeutic range post-surgery; length of stay under 'Hospital-At-Home' care; and episodes of over-coagulation (INR > 4).

Flinders Medical Centre0 个研究点目标入组 140 人开始时间: 2013年7月24日最近更新:
适应症

试验速览

阶段
4 期
状态
撤回
入组人数
140

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Male or Female, > 18 years old
  • -Undergoing elective mechanical heart valve surgery
  • -Able to provide written informed consent, and follow-up by Hospital-at-Home

排除标准

  • -Unable to provide written informed consent
  • -Current atrial fibrillation
  • -Advanced malignancy
  • -Fluctuating thyroid state
  • -Requires emergent/salvage surgery

研究者

相似试验